The serum levels of other inflammatory factors, represented by IL-17 and TNF-α, were also increased in patients with GBS during the acute phase and decreased in the recovery phase, but were still higher than those in HCs (P < .01, Fig. 1e and f). This evidence concerns the gene IL17A and Guillain-Barre syndrome.